NFAT promotes carcinoma invasive migration through glypican-6
about
DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genesNuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerTherapeutic potential of targeting acinar cell reprogramming in pancreatic cancerInsights into the key roles of proteoglycans in breast cancer biology and translational medicineMALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.The motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer.Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinomaHeparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.NFAT as cancer target: mission possible?Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapAAchieving specificity in Akt signaling in cancer.Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling.A mutation in FRIZZLED2 impairs Wnt signaling and causes autosomal dominant omodysplasiaA nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.Multiple Roles of WNT5A in Breast Cancer.NFAT gene family in inflammation and cancer.Boning up on glypicans--opportunities for new insights into bone biology.The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.MicroRNA regulation of proteoglycan function in cancer.FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.The role of heparins and nano-heparins as therapeutic tool in breast cancer.NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A.The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma.Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.Ca2+/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation.
P2860
Q21558457-11BCD27F-86DD-4524-B13B-DA6DD7FFE3F5Q26824937-C638F630-74B2-4EF4-899C-1471F577C8FAQ28068998-28F83AB8-7B86-4E7D-82BC-6E5C7BD77DACQ28085548-F23565D9-D33B-4785-91EC-8668F99543FFQ33727896-60F5BBF4-FA44-4A93-A9B8-3EF0CC49A0FFQ34031745-6365A192-B610-4719-9017-1433833454DEQ34317898-EADC870B-60DA-46DB-B0DF-9A00F140B1AAQ34475894-9A488B62-6A15-4B0E-9702-3EA6C67F0888Q35176376-27ABE446-3055-4CD5-8751-5463F763320DQ35630191-CD4652C8-6B9E-4B15-BF13-807F4BA5F3C9Q35753633-56905F8D-651C-4F1C-9B92-A9E1DDB8F084Q35813723-A48DBA93-E64E-4DBD-847C-E61D5CBC66CEQ36455193-89B977C8-A55D-44ED-A0EC-E199C1F34599Q36545083-DB6310E1-8ABF-472E-940A-5E1BEB5B072FQ36733736-3AC2005F-25B5-4461-8B3F-BE262F6581FDQ36774911-AEC43EEC-C8B1-40A9-84A9-F11465BFA207Q36807636-C277929F-EAA4-42D8-8C7F-C1E155486554Q37109747-AFDA8CF1-EAB8-48C2-86C4-54779B08385AQ37545894-8A408416-3171-4C14-823D-C6CBFFE35966Q38040813-58C74D35-4365-4C85-B7A7-5FF589EFAB35Q38072394-F07D61D5-E889-494D-93F2-4163D39A2FF8Q38175044-C25DAA99-B979-447F-808D-9BE76DD4C151Q38244283-454BE0B6-D6CF-479B-AB71-3187D6F4A453Q38730495-D725A79B-DB71-4C9A-BF0D-5E1AABAE4F70Q38806104-C498D2A2-CC73-466C-9C69-E9D9324D87BCQ38824929-BDA8D8FE-E3CB-46D1-8527-8BE810DB0D12Q38838114-E7132563-129F-4479-8761-3F25294DABCCQ38915508-F5A065BF-769C-4FDF-A323-4BBE5A49BD43Q39141618-14C03F86-5054-4F83-A05F-537EBB13579AQ40452556-26F2B359-56EA-408E-B7C0-563E66D3E5B7Q41022121-6492F13D-F6A0-49CB-8207-675DBC5E7260Q47620298-5C74440C-E6B3-4EEE-94F2-A28B5259CD51
P2860
NFAT promotes carcinoma invasive migration through glypican-6
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
NFAT promotes carcinoma invasive migration through glypican-6
@ast
NFAT promotes carcinoma invasive migration through glypican-6
@en
NFAT promotes carcinoma invasive migration through glypican-6
@en-gb
NFAT promotes carcinoma invasive migration through glypican-6
@nl
type
label
NFAT promotes carcinoma invasive migration through glypican-6
@ast
NFAT promotes carcinoma invasive migration through glypican-6
@en
NFAT promotes carcinoma invasive migration through glypican-6
@en-gb
NFAT promotes carcinoma invasive migration through glypican-6
@nl
prefLabel
NFAT promotes carcinoma invasive migration through glypican-6
@ast
NFAT promotes carcinoma invasive migration through glypican-6
@en
NFAT promotes carcinoma invasive migration through glypican-6
@en-gb
NFAT promotes carcinoma invasive migration through glypican-6
@nl
P2093
P2860
P921
P356
P1433
P1476
NFAT promotes carcinoma invasive migration through glypican-6
@en
P2093
Alex Toker
Aura Kaunisto
Gary K Yiu
Y Rebecca Chin
P2860
P304
P356
10.1042/BJ20110530
P407
P577
2011-11-15T00:00:00Z